BioAge Labs Inc.

3.88
-0.11 (-2.76%)
At close: Mar 27, 2025, 3:59 PM
3.95
2.05%
Pre-market: Mar 28, 2025, 07:00 AM EDT

BioAge Labs Income Statement

Year FY24 FY23 FY22
Revenue n/a n/a n/a
Cost of Revenue n/a n/a n/a
Gross Profit n/a n/a n/a
Operating Income -78.19M -48.4M -39.97M
Interest Income n/a 2.43M 465K
Pretax Income -71.11M -63.85M -39.72M
Net Income -71.11M -63.85M -39.72M
Selling & General & Admin 19.16M 14.51M 9.45M
Research & Development 59.04M 33.89M 30.52M
Other Expenses n/a n/a n/a
Operating Expenses 78.19M 48.4M 39.97M
Interest Expense -2.37M 7.79M 241K
Selling & Marketing Expenses n/a n/a n/a
Cost & Expenses n/a 48.4M 39.97M
Income Tax n/a n/a n/a
Shares Outstanding (Basic) 10.73M 7.47M 7.46M
Shares Outstanding (Diluted) 10.73M 7.47M 7.46M
EPS (Basic) -6.63 -8.55 -5.32
EPS (Diluted) -6.63 -8.55 -5.32
EBITDA -78.19M -55.9M -39.35M
Depreciation & Amortization n/a 162K 129K